UCB (EBR:UCB) UCB Media Room: Disposals of own shares

Directive transparence : information réglementée Communiqué sur comptes, résultats, chiffres d’affaires

04/02/2022 20:04
https://mb.cision.com/Public/18595/logo/86a99b25f755738d_org.jpg ** Disposals of own shares ------------------------------------------------------------ Brussels (Belgium), 4 February 2022 =E2=80=93 20:00 (CET) =E2=80=93 regulat= ed information Disposal of own shares In accordance with article 8:6 of the Royal Decree executing the Belgian Co= de of Companies and Associations, UCB announces that, following exercises o= f stock options by members of its personnel, it has disposed of UCB shares = OTC in view of deliveries of these shares to the relevant members of the pe= rsonnel, within the framework of the Long-Term Incentive Program of the UCB= Group, as follows: https://mb.cision.com/Public/18595/3499416/8d8afdfbd5dca7a9_800x800ar.png This press release is available on UCB SA/NV=E2=80=99s website via the foll= owing link (https://www.ucb.com/stories-media/Press-Releases) . Investor Relations Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 Investor Relations, UCB T +32.2.559.94.14 antje.witte@ucb.com Corporate Communications Laurent Schots=C2=A0 Media Relations, UCB =C2=A0 T+32.2.559.92.64 =C2=A0Laurent.schots@ucb.com=C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With approximately 8 400 peopl= e in nearly 40 countries, the company generated revenue of =E2=82=AC 5.3 bi= llion in 2020. UCB is listed on Euronext Brussels (symbol: UCB). Follow us = on Twitter: @UCB_news =C2=A0 GenericFile 220204 - Disposals of own shares ENG (https://mb.cision.com/Public/18595/34= 99416/a731f367dd46aacd.pdf) GenericFile 220204 - Vervreemding van eigen aandelen NED (https://mb.cision.com/Public/= 18595/3499416/a806958e5cbe88db.pdf) GenericFile 220204 - Ali=C3=A9nation d actions propres FR (https://mb.cision.com/Public= /18595/3499416/b26f09b32831976c.pdf) Image Chart 1 February 04 2022 (https://mb.cision.com/Public/18595/3499416/8d8afd= fbd5dca7a9_org.png) ______________________ If you would rather not receive future communications from UCB SA, please g= o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x95487x1x6868579x24000= x6&Email=3Dregnews%40symexglobal.com. UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium